|
1
|
Waly Raphael S, Yangde Z and Yuxiang C:
Hepatocellular carcinoma: Focus on different aspects of management.
ISRN Oncol. 2012:4216732012.PubMed/NCBI
|
|
2
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bosch FX, Ribes J, Diaz M and Cleries R:
Primary liver cancer: Worldwide incidence and trends.
Gastroenterology. 127:S5–S16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Faivre S, Bouattour M and Raymond E: Novel
molecular therapies in hepatocellular carcinoma. Liver Int. 31
Suppl:S151–S160. 2011. View Article : Google Scholar
|
|
6
|
Pan FC and Wright C: Pancreas
organogenesis: From bud to plexus to gland. Dev Dyn. 240:530–565.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang X, Sun J, Cui M, Zhao F, Ge C, Chen
T, Yao M and Li J: Downregulation of FOXP1 inhibits cell prolife
ration in hepatocellular carcinoma by inducing G1/S phase cell
cycle arrest. Int J Mol Sci. 17:E15012016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Datta J, Kutay H, Nasser MW, Nuovo GJ,
Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, et
al: Methylation mediated silencing of MicroRNA-1 gene and its role
in hepatocellular carcinogenesis. Cancer Res. 68:5049–5058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan X, Zhou H and Zhang T, Xu P, Zhang S,
Huang W, Yang L, Gu X, Ni R and Zhang T: Downregulation of FOXP2
promoter human hepatocellular carcinoma cell invasion. Tumour Biol.
36:9611–9619. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu Z, Lin X, Tian M and Chang W:
microRNA196b promotes cell migration and invasion by targeting
FOXP2 in hepatocellular carcinoma. Oncol Rep. 39:731–738.
2018.PubMed/NCBI
|
|
11
|
Zhang Y, Zhang S, Wang X, Liu J, Yang L,
He S, Chen L and Huang J: Prognostic significance of FOXP1 as an
oncogene in hepatocellular carcinoma. J Clini Pathol. 65:528–533.
2012. View Article : Google Scholar
|
|
12
|
Shi JY, Ma LJ, Zhang JW, Duan M, Ding ZB,
Yang LX, Cao Y, Zhou J, Fan J, Zhang X, et al: FOXP3 Is a HCC
suppressor gene and Acts through regulating the TGF-beta/Smad2/3
signaling pathway. BMC Cancer. 17:6482017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Katoh M and Katoh M: Human FOX gene family
(Review). IntJ Oncol. 25:1495–1500. 2004.
|
|
14
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lam EW, Brosens JJ, Gomes AR and Koo CY:
Forkhead box proteins: Tuning forks for transcriptional harmony.
Nat Rev Cancer. 13:482–495. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barasch J: Genes and proteins involved in
mesenchymal to epithelial transition. Curr Opin Nephrol Hypertens.
10:429–436. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu SQ, Qiu Y, Dai WJ and Zhang XY: FOXR2
promotes the proliferation, invasion, and epithelial-mesenchymal
transition in human colorectal cancer cells. Oncol Res. 25:681–689.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Xia L, Zhou Z, Zuo Z, Xu C, Song H
and Cai J: MiR-186-5p upregulation inhibits proliferation,
metastasis and epithelial-to-mesenchymal transition of colorectal
cancer cell by targeting ZEB1. Arch Biochem Biophys. 640:53–60.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun C, Tao Y, Gao Y, Xia Y, Liu Y, Wang G
and Gu Y: F-box protein 11 promotes the growth and metastasis of
gastric cancer via PI3K/AKT pathway-mediated EMT. Biomed
Pharmacother. 98:416–423. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu L, Wu B, Cai H, Li D, Ma Y, Zhu X, Lv
Z, Fan Y and Zhang X: Tiam1 promotes thyroid carcinoma metastasis
by modulating EMT via Wnt/beta-catenin signaling. Exp Cell Res.
362:532–540. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guan X: Cancer metastases: Challenges and
opportunities. Acta Pharm Sin B. 5:402–418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nordenstedt H, White DL and El-Serag HB:
The changing pattern of epidemiology in hepatocellular carcinoma.
Dig Liver Dis. 42 Suppl:S206–S214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang JD, Harmsen WS, Slettedahl SW,
Chaiteerakij R, Enders FT, Therneau TM, Orsini L, Kim WR and
Roberts LR: Factors that affect risk for hepatocellular carcinoma
and effects of surveillance. Clin Gastroenterol Hepatol. 9:617–623.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai
MH, Liu HC, Zhang RY and Liu C: FoxM1 overexpression promotes
epithelial-mesenchymal transition and metastasis of hepatocellular
carcinoma. World J Gastroenterol. 21:196–213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sanchez-Tillo E, Lazaro A, Torrent R,
Cuatrecasas M, Vaquero EC, Castells A, Engel P and Postigo A: ZEB1
represses E-cadherin and induces an EMT by recruiting the SWI/SNF
chromatin-remodeling protein BRG1. Oncogene. 29:3490–3500. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tam WL and Weinberg RA: The epigenetics of
epithelial-mesenchymal plasticity in cancer. Nature Med.
19:1438–1449. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
